Objective: To determine the effect of transdermal oestrogen replacemen
t therapy on the haemostatic balance of menopausal women. Design: Open
, parallel group, prospective study. Setting: Three hospital-based men
opause clinics. Subjects: Fifty-two postmenopausal women receiving tra
nsdermal hormone replacement therapy (Estrapak 50) for 6 months. Compa
rison group of 48 untreated postmenopausal women studied in parallel.
Main outcome measures: Changes in platelet number, plasma concentratio
ns of coagulation factors and their natural inhibitors, fibrinolytic a
ctivity, and rheological parameters. Results: Estrapak 50 had no signi
ficant thrombophilic effect on any of the outcome measures. Conclusion
: The haemostatic balance and thus the risk of thrombosis would not ap
pear to be upset by this dose of transdermal oestrogen.